KashmirLife

Kashmir Scientist Led Company Raises Rs 20 Cr to Advance Affordable Cancer and Gene Therapies in India

SRINAGAR: In a significant boost to Indias growing biotechnology sector, Cellogen Therapeutics has secured Rs 20 crore (around $2 million) in funding from Kotak Alternate Asset Managers Limited to accelerate its cutting-edge work in cell and gene therapies. The investment, made through Kotak Life Sciences Fund I (KLSF-I), will help the startup expand its CAR-T []